Slager, PhD, endowed professor of lymphoma research at Mayo Clinic, discusses the use of polygenic risk scoring to assess ...

Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...

Reid Merryman, MD, discusses which patients are typically monitored for minimal residual disease and whether there are ...

ENGOT-cx11 is a randomized, double-blind, placebo-controlled trial that enrolled patients aged 18 years or older diagnosed ...

A recent Targeted Oncology survey explores the challenges and best practices in transitioning patients with cancer from inpatient to outpatient care, featuring insights from Cristina Gasparetto, MD, ...

LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.

The open-label portion of the phase 1b/2 ASIST study (NCT05322590) evaluating the combination of BXQ-350 plus standard of care (SOC) for the first-line treatment of patients with metastatic colorectal ...